Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection - Wikidata - awgldk - TriplyDB

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection

http://www.wikidata.org/entity/Q34466521

about

HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia.Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy Neurobehavioral Disturbances During Acute and Early HIV Infection.Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.Immune activation in the central nervous system throughout the course of HIV infection.Proton Chemical Shift Imaging Study of the Combined Antiretroviral Therapy Impact on Neurometabolic Parameters in Chronic HIV Infection.Cognitive Impairment and Persistent CNS Injury in Treated HIV.Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.Resting-state subcortical functional connectivity in HIV-infected patients on long-term cART.COMPARISON BETWEEN PROTON MAGNETIC RESONANCE SPECTROSCOPY FINDINGS IN DOGS WITH TICK-BORNE ENCEPHALITIS AND CLINICALLY NORMAL DOGS.Increased Cortical Cerebral Blood Flow in Asymptomatic Human Immunodeficiency Virus-Infected Subjects.Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.7T Brain MRS in HIV Infection: Correlation with Cognitive Impairment and Performance on Neuropsychological Tests.The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

P2860

Q26766448-49203519-988F-41DB-AB99-1652E9FD45FF Q28066725-4796779B-63A2-4AC3-B096-06E04E65804A Q30250271-438D1D11-6515-44C9-B00C-B53151B53B0E Q33809544-F1D6558A-1A11-4D48-92A1-6A351FA5B0C7 Q35338414-ED1DF029-F7EC-4ACD-855D-BED7D42D53FA Q36463660-FF849404-B207-49CA-86AD-47661AA009E2 Q36725430-378D9BED-2216-4AE1-877E-30C19AB63147 Q37205326-52CE59C3-7D89-4303-B56A-103BFCBCBA0F Q38258410-551532E7-9F08-4733-9735-A41D1D5B75BC Q38374295-4BA0D795-8C05-4119-AE08-FA5F70690329 Q38694693-051F7C24-099B-437D-A912-A68A1C7F2449 Q38827785-AF05465C-4607-4CED-ACD8-2A3AB75DDA28 Q38836472-0ECF06DB-783B-4F15-96DA-471F12DE1366 Q40262441-38B72801-26C5-437B-A024-90B34004AEAF Q40282427-3224EBB1-2D32-49F2-8C72-0BFCF92F86CB Q40294053-184D73C3-50A8-4990-B7EF-31FEDF88FB65 Q40505703-630A1505-FEFD-483F-BAAA-AB1CF8B08A93 Q40550915-FC76FCBF-164B-43BC-86CC-1EA5E4BDF4A4 Q40681934-0378E132-D458-4D41-8914-322489842DA8 Q47193060-E04B5650-5710-4B34-BE11-61CAC6C63323 Q49961078-30EA4929-4928-4B27-8197-6F375008C21F Q53075373-DCA4FCF7-DD42-4065-AD7E-673CFEF2292F

P2860

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection

http://www.wikidata.org/entity/Q34466521

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@ast

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@en

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@nl

type

label

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@ast

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@en

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@nl

prefLabel

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@ast

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@en

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@nl

P1433

Q34466521-4687CEA5-C810-421D-A447-00A2210EE78C

P1476

Q34466521-3521058C-6B11-4392-B98E-182FD3DD9E9E

P2093

Q34466521-029A7898-F29F-4B5A-ADA1-3F3A4C7E4A0F

Q34466521-12A636E7-3E00-442A-846A-D2241042E266

Q34466521-1E6A2DCF-CC57-4CB6-B65E-6166C09C919D

Q34466521-641A2900-76D3-4AB5-9B8D-A899FE602441

Q34466521-730E660E-45DB-4F37-8F38-879EBD446C84

Q34466521-81A343EA-D7D3-40A7-A6B4-27E96915B5FA

Q34466521-9165DF86-B997-4B4C-9205-9B990D9BDE5A

Q34466521-FFF92C10-57F5-4C28-9440-C83532DB02EB

P2860

Q34466521-09721B61-37BF-41F4-AF41-25894F8F4D9B

Q34466521-0FFD2204-5F08-4542-BC8A-3E565D1DC454

Q34466521-2391E9A6-A289-4F20-8A07-9BEFCC3BBA8E

Q34466521-259EA5D5-FB7F-4D58-920A-C5A043EA7D31

Q34466521-2C3B8200-B4DB-40F3-A9B3-A57CEAFEA403

Q34466521-3043EB72-9ABC-46FB-82A1-6599DCF13B22

Q34466521-34F22B08-5BD5-4713-859E-2CB8108F7A6B

Q34466521-37D23049-BD4C-4126-A495-579E98760068

Q34466521-3A6877FD-BA32-40AC-8D7C-E29772FBE603

Q34466521-40CEA5C4-4E92-4A30-881A-B62C5A3378D2

P304

Q34466521-DEE3D5A4-E61E-47E0-AD5E-5B87BE46AF9A

P31

Q34466521-729F4380-D859-4974-9E9C-2D2DB92F3B62

P356

Q34466521-D470D4EB-18DF-476D-A3BA-0CC34B4787FD

P407

Q34466521-6531B615-3682-4D5F-B7BF-F496B23C7BFC

P433

Q34466521-88763199-5B32-42F1-A241-3C4D16683D27

P478

Q34466521-0411D9CB-796E-498A-9AFC-C35E904594D5

P50

Q34466521-B98C46AF-1C1F-4B2C-826E-3D2657400B64

P577

Q34466521-25104237-9568-4BC6-8210-1A7E3AC16B1F

P698

Q34466521-8BC04B28-E978-4DD5-9A99-73B31C9FD3A8

P921

Q34466521-D82DDE87-F205-4198-92CF-EDD81E751D12

P932

Q34466521-E6797BA6-3289-45FB-97D0-BB0764D39AEF

P356

WNL.0000000000000932

P1433

P1476

Cerebral metabolite changes pr ...... erapy in primary HIV infection

@en

P2093

Andrew C Young

http://www.w3.org/2001/XMLSchema#string

Dieter J Meyerhoff

http://www.w3.org/2001/XMLSchema#string

Evelyn Lee

http://www.w3.org/2001/XMLSchema#string

Julia Peterson

http://www.w3.org/2001/XMLSchema#string

Manu Hegde

http://www.w3.org/2001/XMLSchema#string

Richard W Price

http://www.w3.org/2001/XMLSchema#string

Rudy Walter

http://www.w3.org/2001/XMLSchema#string

Serena Spudich

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDS

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study.

In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain.

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection.

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

P304

1592-1600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000000932

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Constantin T Yiannoutsos

P577

2014-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25261502

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4223087

http://www.w3.org/2001/XMLSchema#string